Compelling benefit of soluble suppression of tumorigenicity-2 in post-myocardial infarction estimation of risk: The time is right for its routine use in the clinic
- Díez, J.
- Bayes-Genis, A.
Zeitschrift:
Journal of the American Heart Association
ISSN: 2047-9980
Datum der Publikation: 2017
Ausgabe: 6
Nummer: 10
Art: Verlag
